Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.66 |
| ▸ | XDH | P47989 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.44 |
| ▸ | GDA | Q9Y2T3 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | TMIGD3 | P0DMS9 | 1/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
| ▸ | HTR2B | P41595 | 1/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8719273 | 0.98 | DPP4 (0.63) | DPP4XDHKDM4EPDPK1GDA | |
| Hydrochloric Acid SCHEMBL4763244 | 0.98 | DPP4 (0.63) | DPP4XDHKDM4EPDPK1GDA | |
| SCHEMBL11456967 | 0.98 | DPP4 (0.63) | DPP4XDHKDM4EPDPK1GDA | |
| Alcohol SCHEMBL27897029 | 0.89 | DPP4 (0.54) | DPP4XDHKDM4ESMN1; SMN2TMIGD3 | |
| Purine SCHEMBL10869621 | 0.82 | KDM4E (0.50) | DPP4XDHKDM4ESMN1; SMN2TMIGD3 | |
| Tetrabuthylammonium SCHEMBL3029323 | 0.81 | POLA1 (0.48) | DPP4XDHADORA3 | |
| SCHEMBL2997392 | 0.79 | DPP4 (0.61) | DPP4XDHKDM4EPDPK1GDA | |
| 6-Chloroguanine SCHEMBL64059 | 0.79 | DPP4 (1.00) | DPP4PDPK1GDA | |
| SCHEMBL1551198 | 0.79 | DPP4 (0.61) | DPP4XDHKDM4EPDPK1GDA | |
| SCHEMBL2352414 | 0.79 | DPP4 (0.61) | DPP4XDHKDM4EPDPK1GDA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2319 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122036730-A | Gαq/11 protein inhibitor with purine skeleton, and preparation method and application thereof | 中山大学 | 2026-05-15 | — | — | CN | claimed |
| US-20250195498-A1 | INHIBITOR OF CELLULAR PURINE NUCLEOTIDE SALVAGE PATHWAY ENZYME FOR USE IN THE TREATMENT AND/OR PREVENTION OF HELICOBACTER PYLORI INFECTION AND/OR DISEASE ASSOCIATED WITH SUCH INFECTION AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | UNIWERSYTET WARSZAWSKI (PL) | 2025-06-19 | — | — | US | claimed |
| WO-2025129105-A1 | COMPOSITION AND METHOD FOR DETECTION OF BIOMOLECULES VIA AROMATIC LABELING USING HETEROCYCLIC COMPOUNDS | Life Technologies Corporation (US) | 2025-06-19 | — | — | WO | claimed |
| EP-4560315-A2 | HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES | F. Hoffmann-La Roche AG (CH) | 2025-05-28 | — | — | EP | claimed |
| CN-120025362-A | Responsive prodrug, preparation method and application thereof | 上海大学 | 2025-05-23 | — | — | CN | claimed |
| EP-3980554-B1 | HYBRIDIZING ALL-LNA OLIGONUCLEOTIDES | HOFFMANN LA ROCHE (CH) | 2025-03-26 | — | — | EP | claimed |
| CN-118515713-A | Iridium (III) complex photosensitizer based on purine ligand, preparation method and application | 四川大学 | 2024-08-20 | — | — | CN | claimed |
| CN-117986256-A | Aggregation-induced emission type photosensitizer based on purine skeleton and preparation method and application thereof | 四川大学 | 2024-05-07 | — | — | CN | claimed |
| CN-117987495-A | Synthesis method of 2, 6-dichloropurine nucleoside | 上海瑞合达医药科技有限公司 | 2024-05-07 | — | — | CN | claimed |
| CN-117467726-B | Preparation method of purine nucleoside | 天津凯莱英生物科技有限公司 | 2024-04-16 | — | — | CN | claimed |
| US-5118800-A | Oligonucleotides possessing a primary amino group in the terminal nucleotide | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 1992-06-02 | — | — | US | claimed |
| EP-0152965-B1 | PROCESS FOR PREPARING 2,6-SUBSTITUTED-9-(1,3-DIHYDROXY-2-PROPOXY-MENTHYL)-PURINES AND CERTAIN DERIVATIVES | SYNTEX (U.S.A.) INC. (US) | 1990-10-24 | — | — | EP | claimed |
| EP-0391411-A2 | 3'-Substituted methyl nucleosides as antiviral agents | Bristol-Myers Squibb Company (US) | 1990-10-10 | — | — | EP | claimed |
| EP-0173059-B1 | METHOD FOR THE PRODUCTION OF 2'-DEOXYADENOSINE COMPOUNDS | BRIGHAM YOUNG UNIVERSITY (US) | 1989-11-29 | — | — | EP | claimed |
| US-4801710-A | Regioselective synthesis of 9-substituted purine acyclonucleoside derivatives | MERCK & CO., INC. (US) | 1989-01-31 | — | — | US | claimed |
| US-4760137-A | Method for the production of 2'-deoxyadenosine compounds | BRIGHAM YOUNG UNIVERSITY (US) | 1988-07-26 | — | — | US | claimed |
| US-4621140-A | Process for preparing 2,6-substituted-9-(1,3-dihydroxy-2-propoxymethyl)-purines and certain derivatives | SYNTEX (U.S.A.) INC. (US) | 1986-11-04 | — | — | US | claimed |
| EP-0184473-A1 | Regioselective synthesis of 9-substituted purine acyclonucleoside derivatives | MERCK & CO. INC. (US) | 1986-06-11 | — | — | EP | claimed |
| EP-0173059-A2 | Method for the production of 2'-deoxyadenosine compounds | BRIGHAM YOUNG UNIVERSITY (US) | 1986-03-05 | — | — | EP | claimed |
| EP-0152965-A2 | Process for preparing 2,6-substituted-9-(1,3-dihydroxy-2-propoxy-menthyl)-purines and certain derivatives | SYNTEX (U.S.A.) INC. (US) | 1985-08-28 | — | — | EP | claimed |